The Institute for Clinical and Translational Research (ICTR) is a community-academic partnership that is improving the transfer of biomedical and health sciences discoveries into practical use in health-care providers' offices, clinics, hospitals, and communities. The institute originated in 2007 with a five-year, $41 million grant from the National Institutes of Health to the University of Wisconsin–Madison.
La Follette School faculty collaborate with the ICTR's Community Academic Partnerships core and represent the campus’ Health Policy Group on the grant’s steering committee. That committee selects proposals submitted by public affairs and other faculty to evaluate the adoption of health-care innovations in Wisconsin.
Two such assessments involve La Follette students and faculty studying the cost effectiveness of early detection and treatment of Alzheimer’s disease and improvements in the care of diabetes patients. A third project is exploring the adoption and diffusion of evidence-based innovations, including Antabuse, Campral, naltrexone, and burprenorphine, that are used in treating alcohol and drug addiction. Funding from the School of Medicine and Public Health's Medical Education and Research Committee supports this work.
The ICTR is a collaboration of four university health sciences schools — Medicine and Public Health, Nursing, Pharmacy, and Veterinary Medicine — and the College of Engineering. A strong partnership with Marshfield Clinic and its research arm, the Marshfield Clinic Research Foundation, is also a key feature.